Introduction
There has been a paradigm shift in recent years from a focus primarily on the role of the systemic renin-angiotensin system (RAS) in the regulation of arterial pressure and in the pathophysiology of hypertension, to an emphasis on the changes in the components of the RAS at the tissue level in various organs. Emphasis in this article is on the renal RAS because of its unique significance in regulating sodium balance and thus long-term arterial pressure [1] , and its role in the progression of renal diseases [2••] . Indeed, there is growing recognition that inappropriate activation of the intrarenal RAS limits the capability of the kidney to maintain sodium balance at normal arterial pressures and is an important cause of hypertension [1,3•,4,5] . In addition to sodium and fluid retention and progressive hypertension, there are critical long-term consequences of an inappropriately elevated RAS coexisting with hypertension, which lead to proliferative responses and vascular, glomerular, and tubular interstitial injury, and fibrosis [2••,3•,6,7•,8-11] .
Regardless of the mechanism responsible for an overactive intrarenal RAS, the consequent impairment in sodium excretory capability contributes to the development of hypertension [1, 4] . Varying degrees of reduced renal function have been found in many hypertensive patients associated with inappropriate activation of the RAS as reflected by their responsiveness to angiotensinconverting enzyme (ACE) inhibitors or angiotensin II (Ang II) receptor blockers, even when plasma renin levels are not elevated [12•,13-16] . The important role of the RAS is also supported by studies using various experimental models of hypertension having an overactive RAS. Specific examples include 2 kidney, 1 clip (2K1C) Goldblatt hypertension [17,18,19•,20] , Ang II-infused hypertension [4], the transgenic rat (TGR) (mRen2) model harboring an extra renin gene in its genome [21] , the remnant kidney model produced by unilateral nephrectomy plus ligation of arterial branches in the remaining kidney [22, 23] , and several mouse models that overexpress renin or angiotensinogen (AGT) [24] [25] [26] .
Intrarenal Angiotensin II Receptors
The AT 1 receptor is the predominant Ang II receptor in the kidneys of adults and is widely distributed in essentially all regions and cell types, leading to a large number of directly mediated actions or activation by other paracrine systems [27] . AT 1 receptor protein has been localized to vascular smooth muscle cells throughout the renal vasculature, including both afferent and efferent arterioles, mesangial cells and vasa recta, proximal tubule brush border and basolateral membranes, thick ascending limb epithelia, distal tubule cells, collecting duct cells, glomerular podocytes, and macula densa cells [27] [28] [29] [30] [31] [32] [33] [34] . Importantly, there is extensive luminal localization of AT 1 receptors in both proximal and distal nephron segments. In rodents, the AT 1A is the predominant subtype, but AT 1A and AT 1B receptor mRNAs have been demonstrated in the glomerulus and in all nephron segments including the proximal tubule, distal tubule, thick ascending limb, and collecting ducts [30, 34, 35 ]. Some of the major renal actions reported Elevations in intrarenal angiotensin II (Ang II) cause reductions in renal function and sodium excretion that contribute to progressive hypertension and lead to renal and vascular injury. Augmentation of intrarenal Ang II occurs by several processes, leading to levels much greater than can be explained from the circulating levels. In Ang IIdependent hypertension, Ang II is internalized via an AT1 receptor mechanism, but there is also sustained intrarenal production of Ang II. Ang II exerts a positive feedback action on intrarenal angiotensinogen (AGT) mRNA and protein. The increased intrarenal AGT production is associated with increased intrarenal and intracellular Ang II contents and urinary AGT excretion rates. The increased urinary AGT indicates spillover of AGT into distal nephron segments supporting enhanced distal Ang II formation and sodium reabsorption. The augmentation of intrarenal Ang II provides the basis for sustained actions on renal function, sodium excretion, and maintenance of hypertension.
for Ang II acting on AT 1 and AT 2 receptors are depicted in Figure 1 . The role of AT 2 receptors in mediating vascular injury remains controversial. Some investigators have demonstrated that AT 2 receptors may contribute to pathobiology of vascular cells rather than being protective as is generally stated [2••,11] .
The regulation of intrarenal Ang II receptors in hypertensive models is complex since vascular and tubular receptors respond differently during high Ang II states [27] . In general, high Ang II levels associated with a low-salt diet decrease glomerular AT 1 receptor expression but increase tubular AT 1 receptor levels [36] . Studies in 2K1C Goldblatt hypertensive rats demonstrated that glomerular AT 1 receptors were decreased by 2 weeks after clipping, but vascular receptors were not decreased until 16 weeks [37] . However, glomerular AT 1 receptor density was not increased in the 1K1C model, although vascular AT 1 receptor density was increased [38] .
In the Ang II-infused model of hypertension, total kidney AT 1 mRNA levels and receptor protein were not significantly altered by 2 weeks of Ang II infusion sufficient to cause marked hypertension [39] . However, Wang et al. [29] reported that AT 1A receptor protein was reduced in ischemic and contralateral kidneys of 2K1C Goldblatt and 2 kidney, 1 wrap hypertensive models and in kidneys of Ang II-infused rats. AT 2 receptors were downregulated only in ischemic kidneys. In the TGR (mRen2) harboring the mouse renin gene, Zhuo et al. [40] found increased AT 1 receptor binding in vascular smooth muscle of afferent and efferent arterioles, juxtaglomerular apparatus, glomerular mesangial cells, proximal tubular cells, and renomedullary interstitial cells. It was suggested that upregulation of AT 1 receptors in multiple renal cells may contribute to the pathogenesis of hypertension in these rats. HarrisonBernard et al. [41] extended the analysis in Ang II-infused rats with in vitro autoradiography and showed differential responses with significant decreases in glomeruli and inner stripe but not in proximal tubules. Furthermore, ACE binding was significantly increased in proximal tubules of Ang II-infused rats. Thus, the data suggest that the vascular and glomerular AT 1 receptors are downregulated, but the proximal tubular receptors are either upregulated or not significantly altered in Ang II-dependent hypertension.
Intrarenal Levels of Angiotensin II
In response to variations in dietary sodium intake, total renal renin, Ang I, and Ang II levels respond in a coordinated manner [27, [42] [43] [44] . In addition to intrarenal conversion of Ang II from systemically delivered Ang I, intrarenal Ang II is also derived from intrarenally formed Ang I originating from either circulating or locally formed AGT. Indeed, van Kats et al. [45•] found that under normal conditions most of the intrarenal Ang II and Ang I was derived from local production. They infused labeled Ang I and Ang II systemically into pigs and compared the tissue contents of labeled and endogenous peptides produced from locally generated Ang I. They also reported that renal tissue Ang II was not significantly reduced by treatment with an ACE inhibitor, suggesting the presence of alternative Ang II-forming pathways. However, studies in rats by Komine et al. [46] showed that chronic treatment with an ACE inhibitor, an AT 1 receptor blocker, and the combination of an ACE inhibitor as well as an AT 1 receptor blocker lowered renal tissue Ang II contents in rats maintained on a low-salt diet to stimulate the RAS. They found that the combination lowered renal Ang II content to a greater extent than either treatment alone.
Although under normal physiologic conditions plasma and kidney renin activities change in concert with plasma and kidney Ang I and Ang II levels [42, 43] , these relationships can be disrupted in some forms of hypertension [5] . This has been shown in 2K1C Goldblatt hypertension, Ang II-induced hypertension, and TGR (mRen2) hypertensive models [5,19•] . The net intrarenal Ang II content is due to formation of intrarenal Ang II as well as sequestration of Ang II from the circulation via an AT 1 receptor-mediated process [5,47,48•] . This is particularly apparent when there are sustained elevations in circulating Ang II, which cause progressive accumulation of intrarenal Ang II levels even under conditions of marked suppression of renin formation and release such as occurs in the nonclipped kidney of 2K1C Goldblatt hypertensive rats [18] , Ang IIinfused hypertensive rats [49•], and TGR (mRen2) [50] . The remnant kidney model of hypertension has elevated renin and intrarenal Ang II levels primarily in the periinfarct borders [22] . It is important to emphasize that much of the increase in intrarenal Ang II that occurs during chronic Ang II infusion is due to an AT 1 receptordependent process since it can be prevented by concomitant treatment with AT 1 receptor blockers, suggesting receptor-mediated endocytosis [47,49•] . As recently shown by Ingert et al. [48•] , uptake of Ang II via AT 1 receptors also contributes to the increase in renal Ang II levels that occur with low-salt intake.
A recent study by Tokuyama et al. [19•] provides further support to the important role of locally formed intrarenal Ang II in hypertension models. Using a dog 2K1C Goldblatt hypertensive model, they demonstrated significant increases in intrarenal Ang II in both the clipped and nonclipped kidneys. However, ACE activity was increased only in the nonclipped kidney, but not in the clipped kidney. Interestingly, the elevated Ang II in the clipped kidney was suppressed by a chymase inhibitor, suggesting a role for chymase in Ang II formation in the clipped kidney. This study demonstrated that Ang II levels are elevated in both clipped and nonclipped kidneys, however, the mechanisms for Ang II generation may differ. These findings were extended in a recent paper by Sadjadi et al. [20] who found that intrarenal Ang II levels were increased in both the clipped and unclipped kidneys of 2K1C Goldblatt hypertensive rats, not only during the
